These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3276481)

  • 1. Stress and autonomic nervous system in type II diabetes. A hypothesis.
    Surwit RS; Feinglos MN
    Diabetes Care; 1988 Jan; 11(1):83-5. PubMed ID: 3276481
    [No Abstract]   [Full Text] [Related]  

  • 2. Islet function and stress hyperglycemia: plasma glucose and epinephrine interaction.
    Halter JB; Beard JC; Porte D
    Am J Physiol; 1984 Jul; 247(1 Pt 1):E47-52. PubMed ID: 6377920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-insulin-dependent diabetes.
    Lancet; 1985 Jul; 2(8446):104-5. PubMed ID: 2861519
    [No Abstract]   [Full Text] [Related]  

  • 4. Emerging concepts in the pathophysiology of type 2 diabetes mellitus.
    Surampudi PN; John-Kalarickal J; Fonseca VA
    Mt Sinai J Med; 2009 Jun; 76(3):216-26. PubMed ID: 19421965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain glucose sensing and neural regulation of insulin and glucagon secretion.
    Thorens B
    Diabetes Obes Metab; 2011 Oct; 13 Suppl 1():82-8. PubMed ID: 21824260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characteristics of insulin secretion in persons with glucose tolerance disorders and in patients with type II diabetes mellitus].
    Starosel'tseva LK; Gonzales R; Perich R; Rodriges B; Klaro A
    Probl Endokrinol (Mosk); 1983; 29(5):3-8. PubMed ID: 6359133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose toxicity: the implications of hyperglycemia in the pathophysiology of diabetes mellitus.
    Rossetti L
    Clin Invest Med; 1995 Aug; 18(4):255-60. PubMed ID: 8549010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon-like peptide-1 and diabetes.
    Monami M
    Exp Diabetes Res; 2011; 2011():901954. PubMed ID: 22203831
    [No Abstract]   [Full Text] [Related]  

  • 9. The relative importance of nervous system and hormones to the 2-deoxy-D-glucose-induced hyperglycemia in fed rats.
    Matsunaga H; Iguchi A; Yatomi A; Uemura K; Miura H; Gotoh M; Mano T; Sakamoto N
    Endocrinology; 1989 Mar; 124(3):1259-64. PubMed ID: 2563682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic changes in diabetes.
    Leslie RD
    Eye (Lond); 1993; 7 ( Pt 2)():205-8. PubMed ID: 7607335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sympathetic nervous system and experimental diabetes: role of adrenal medullary hormones.
    Kaul CL; Ramarao P
    Prog Drug Res; 2001; 57():163-80. PubMed ID: 11728001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type II diabetes mellitus.
    Edelman SV
    Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperglycaemia is associated with impaired pulsatile insulin secretion: effect of basal insulin therapy.
    Meier JJ; Pennartz C; Schenker N; Menge BA; Schmidt WE; Heise T; Kapitza C; Veldhuis JD
    Diabetes Obes Metab; 2013 Mar; 15(3):258-63. PubMed ID: 23039360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type II diabetes, glucose "non-sense," and islet desensitization.
    Robertson RP
    Diabetes; 1989 Dec; 38(12):1501-5. PubMed ID: 2684709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining the effects of hyperglycemia on pancreatic endocrine function in humans: evidence for in vivo glucotoxicity.
    Solomon TP; Knudsen SH; Karstoft K; Winding K; Holst JJ; Pedersen BK
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4682-91. PubMed ID: 23043193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stress and diabetes mellitus.
    Surwit RS; Schneider MS; Feinglos MN
    Diabetes Care; 1992 Oct; 15(10):1413-22. PubMed ID: 1425110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The metabolic characteristics of isolated impaired fasting glucose and fasting hyperglycemia].
    Tian JY; Li G; Gu YY; Zhang XL; Li FY; Zhou WB; Zhang HL; Wang X; Luo TH; Luo M
    Zhonghua Nei Ke Za Zhi; 2007 Jul; 46(7):555-8. PubMed ID: 17959077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glucotoxicity and insulin secretion. An excessively reductionistic formulation].
    Portha B; Ktorza A
    Journ Annu Diabetol Hotel Dieu; 1996; ():121-31. PubMed ID: 8965414
    [No Abstract]   [Full Text] [Related]  

  • 19. Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus.
    Shah P; Vella A; Basu A; Basu R; Schwenk WF; Rizza RA
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4053-9. PubMed ID: 11095432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central infusion of leptin improves insulin resistance and suppresses beta-cell function, but not beta-cell mass, primarily through the sympathetic nervous system in a type 2 diabetic rat model.
    Park S; Ahn IS; Kim DS
    Life Sci; 2010 Jun; 86(23-24):854-62. PubMed ID: 20388519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.